Objectives-To evaluate perinatal outcomes in singleton and twin pregnancies with pathologically confirmed velamentous cord insertion without vasa previa.
V elamentous cord insertion, or insertion of the umbilical vessels into the fetal membranes ( Figure 1 ) rather than the placenta (Figure 2 ), affects 0.4% to 2.4% of pregnancies. 1, 2 Although velamentous cord insertion has been associated with adverse maternal and perinatal outcomes, these observations are potentially confounded by including pregnancies with coexisting vasa previa. [2] [3] [4] [5] In addition, other investigations evaluated data obtained from administrative databases, raising the possibility of ascertainment and selection biases. 3, 4, 6, 7 Furthermore, pathologic confirmation of velamentous cord insertion is often unavailable. [2] [3] [4] [6] [7] [8] Finally, studies have been restricted to singleton gestations despite an increased prevalence of velamentous cord insertion in twins. [1] [2] [3] [4] [5] [6] [7] 9, 10 Therefore, we performed a retrospective case-control study to evaluate perinatal outcomes in both singleton and twin pregnancies complicated by pathologically proven velamentous cord insertion unaccompanied by vasa previa.
Conceivably, prenatal diagnosis of velamentous cord insertion might alter obstetric care and decrease associated perinatal complications. Although current guidelines for obstetric ultrasound examinations recommend evaluating the placental umbilical cord insertion site, few data describe the sensitivity of prenatal ultrasound for detecting velamentous cord insertion, with widely varying results. 5, [8] [9] [10] [11] [12] [13] [14] Therefore, a secondary objective was to examine the ultrasound detection rate and factors potentially associated with prenatal diagnosis.
Materials and Methods
This retrospective case-control study included all nonanomalous singleton and twin pregnancies with pathologically confirmed velamentous cord insertion delivered in a single tertiary center between January 1, 2005, and July 1, 2015, and having at least 1 ultrasound examination by the maternal-fetal medicine service. All ultrasound examinations were performed by registered diagnostic medical sonographers and interpreted by maternal-fetal medicine physicians in an American Institute of Ultrasound in Medicine-accredited practice. Examinations before 2006 were performed with an HDI 5000 ultrasound system (Philips Healthcare, Bothell, WA). During and after 2006, studies were performed with Voluson E8 machines (GE Healthcare, Milwaukee, WI). All examinations conformed to American Institute of Ultrasound in Medicine guidelines. Throughout the study period, the practice's imaging protocol included visualizing the placental umbilical cord insertion when possible during the second and third trimesters. Color Doppler imaging for this purpose was used at the discretion of the sonographer or sonologist and was routinely used to assess the region of the internal cervical os for the presence of vasa previa. Vasa previa was diagnosed when a fetal vessel traversed the membranes within 2 cm of the internal cervical os. In our practice, marginal cord insertions were diagnosed when within 2 cm of the placental margin and velamentous cord insertions were diagnosed when the vessels appeared to insert into the fetal membranes. 15 Pregnancies with velamentous cord insertion were identified through a search of the pathology department's computerized database. In our institution, placental pathologic examinations are not performed routinely but by indication. Indications include those listed in current guidance as well as polyhydramnios, oligohydramnios, substance abuse, prior stillbirth, 42 weeks' gestation or later, meconium-stained amniotic fluid, 5-minute Apgar score of 3 or less, and umbilical arterial cord pH of less than 7.20. 16 These patients were then cross-referenced with the maternal-fetal medicine computerized image archiving and reporting system. Singleton gestations were matched to the next 2 consecutive deliveries without a velamentous cord insertion for gestational age at delivery 6 1 week. Twin pregnancies were matched to the next 2 consecutive twin deliveries without a velamentous cord insertion for gestational age at delivery 6 1 week, as well as chorionicity and amnionicity. Monoamniotic twins were excluded, as were pregnancies with fetal anomalies, gestational age at delivery before 23 weeks, and vasa previa.
Primary outcomes included cesarean or surgical vaginal delivery for a nonreassuring intrapartum fetal heart rate pattern, umbilical arterial cord pH of less than 7.20, 5-minute Apgar score of less than 7, birth weight below the 10th percentile for gestational age, 17, 18 neonatal intensive care unit (NICU) admission, fetal or neonatal death, and cord avulsion at delivery requiring manual placental extraction. Secondary outcomes included the prenatal velamentous cord insertion ultrasound detection rate and factors associated with prenatal velamentous cord insertion diagnosis. Data for patients with velamentous cord insertion and controls were abstracted from ultrasound reports, prenatal records, and inpatient records. Singletons and twins were analyzed separately. The study received an Institutional Review Board exemption based on retrospective evaluation of existing data.
Descriptive data were summarized as mean6 standard deviation or median (range), as appropriate, for continuous data and as frequency (percent) for categorical data. For continuous variables, differences between subgroups were evaluated by t tests or the Mann-Whitney U test, as appropriate, and odds ratios (ORs) were calculated by logistic regression. For frequencies, differences between subgroups and ORs were evaluated by a continuity-corrected v 2 test, using the Fisher exact test for differences, as appropriate. Data for twins were evaluated by pregnancy rather than by fetus; thus, a pregnancy was included in the velamentous cord insertion group if at least 1 fetus had a velamentous cord insertion. Similarly, if either fetus had one of the outcomes measured, it was assigned to the pregnancy. The exception to this approach was in determining the prenatal ultrasound detection rate of velamentous cord insertion in twins, which used the total number of twin fetuses with velamentous cord insertion that were imaged during the second or third trimesters as the denominator. All analyses were performed with SPSS version 24 statistical software (IBM Corporation, Armonk, NY).
Results
Eighty-four of 25,597 (0.33%) singletons and 37 of 2032 (1.82%) twin pregnancies had velamentous cord insertion, for an overall 0.44% prevalence. Fifty-three singletons met inclusion criteria, of which 3 were matched to 1 control, providing 53 patients with velamentous cord insertion and 103 controls for analysis. Thirty-three twin pregnancies met inclusion criteria, of which 1 was matched to 1 control, providing 33 twin pregnancies and 65 controls for analysis. In 3 twin pairs, both fetuses had velamentous cord insertion. The mean gestational ages at ultrasound were 22.8 6 5.2 weeks for singleton and 20.6 6 3.8 weeks for twin cases. Demographics were similar among pregnancies with and without velamentous cord insertion for both singletons (Table 1) and twins (Table 2 ). Singleton pregnancies with velamentous cord insertion were significantly more likely to have placental abruption than those without velamentous cord insertion. Two of these pregnancies were complicated by preeclampsia. No other differences in obstetric factors were observed by the presence of (Table 3) or twins (Table 4) . Primary outcomes occurring significantly more often among singleton pregnancies with velamentous cord insertion were umbilical arterial cord pH of less than 7.2, 5-minute Apgar score of less than 7, and cord avulsion requiring manual placental extraction. The data also suggested an association with surgical delivery for a nonreassuring fetal heart rate pattern, birth weight below the 10th percentile, and fetal or neonatal death in this group (Table 5) . One fetal and 1 neonatal death occurred. The fetal death was diagnosed at 33 weeks' gestation in conjunction with a thrombosed umbilical cord in a mother with protein S deficiency. The neonatal death was attributed to complications of prematurity after emergent delivery at 24 weeks' gestation for a large placental abruption.
Among twins, only a significant increase in fetal or neonatal death was observed in pregnancies with a velamentous cord insertion (Table 6 ). One set of monochorionic diamniotic twins previously treated with amnioreduction for twin-twin transfusion syndrome had rupture of the dividing membrane as a result of the procedure. Death of 1 fetus and a nonreassuring biophysical profile in the surviving twin led to emergent cesarean delivery at 24 weeks' gestation. The live-born twin subsequently died of complications of prematurity. A second set of monochorionic diamniotic twins with twin-twin transfusion syndrome presented at 27 weeks' gestation with death of 1 twin, followed by cesarean delivery of Body mass index data were available for 32, and race data were available for 31. Two patients with abruptions also had preeclampsia. Tables 7 and 8 ). In singletons and twins, increased detection of velamentous cord insertion was suggested with anterior placentas (Table  7) , whereas among twins, decreased detection was suggested with posterior placentas (Table 8 ). The detection rates did not vary between the first and second halves of the study period.
Discussion
Our data show that pathologically confirmed velamentous cord insertion without coexisting vasa previa is associated with adverse perinatal outcomes in singleton and twin pregnancies. Similar to this study, previous investigators also found increased prevalence of 5-minute Apgar scores of less than 7, 1,3,9 cord avulsion and manual placental extraction, 4,7 surgical delivery, 3,9,19 birth weight below the 10th percentile, 2, 3, 7, 9 and fetal or neonatal death. 1, 3, 7 An increased frequency of placental implantation abnormalities such as placental abruption was noted in our and others' work. 3, 5, 9 Authors speculate that velamentous cord insertion and aberrant placental implantation may share similar developmental origins such as trophotropism, in which placental development and remodeling favor uterine regions offering optimal perfusion. 3, 11, 15 The observed association of velamentous cord insertion with low umbilical cord pH is new but not surprising in the context of our patients' perinatal outcomes. Previous investigations also noted modestly increased preterm birth rates [1] [2] [3] 5, 7, 9 and correspondingly increased NICU admissions. 2, 3 We could not evaluate the former association, as cases and controls were matched for gestational age at delivery. This method also likely explains the similar NICU admission rates that were observed among cases and controls.
Our study was unique in that outcomes were specifically evaluated in twin pregnancies. The only primary outcome significantly associated with velamentous cord insertion in this population was fetal or neonatal death. The fetal and neonatal deaths in twins with velamentous cord insertion were attributable, at least in part, to complications of monochorionic twinning and their treatment. We speculate that the earlier mean gestational age at delivery and higher cesarean rate seen in twins versus singletons reduced twins' exposure and the duration of exposure to in utero conditions associated with the primary outcomes.
This investigation also examined factors associated with prenatal ultrasound diagnosis of velamentous cord insertion, suggesting that a lower maternal BMI and anterior placentas are associated with improved detection, whereas lower detection rates occur in twins with posterior placentas. Imaging the placental cord insertion is recommended when possible.
14 Under research conditions that include the routine use of color Doppler ultrasound, the placental cord insertion may be visualized in 99% of pregnancies or more. 8, 12 However, contemporary data regarding visualization in clinical practice are lacking. The reported sensitivity of ultrasound for detecting velamentous cord insertion under research conditions ranges from 22.2% to 100%. 8, 12, 18, 19 Studies with complete velamentous cord insertion ascertainment also routinely used color Doppler imaging but included only 5 and 7 velamentous cord insertion cases, respectively. 8, 12 In routine clinical practice, reported velamentous cord insertion detection rates vary from 0% to 13.9%. 1, 5 Thus, our detection rates of 32.1% in singletons and 28.6% in twins compare favorably. Nonetheless, velamentous cord insertion detection rates remain disappointing. Potential contributors include lack of consistent and reliable diagnostic ultrasound criteria and placental cord insertion imaging protocols. Variations in operator skill and persistence in visualizing the insertion site cannot be discounted. As noted earlier, velamentous cord insertion may develop after placental remodeling later in pregnancy, precluding detection during routine second-trimester ultrasound examinations. 11, 18 This study had several strengths. All cases of velamentous cord insertion were confirmed by placental pathologic examinations. Vasa previas and anomalous fetuses were excluded to avoid confounding outcomes resulting from complications or management of these conditions. Data were obtained directly from clinical records, reducing the likelihood of biases associated with administrative databases. Restricting the analysis to inborn pregnancies ensured complete neonatal follow-up. Twins, analyzed separately from singletons, were included to address an important current knowledge gap. Matching twin cases to controls for amnionicity and chorionicity removed these variables as potential confounders.
We recognize several limitations as well. The retrospective design precluded determining whether velamentous cord insertion caused or was only associated with the observed outcomes. Since the analysis was limited to pathologically confirmed velamentous cord insertion, there was the possibility of an ascertainment bias. Conceivably, a placental pathologic examination was more likely to be requested after an adverse perinatal outcome or delivery of a placenta with visible abnormalities. However, such a bias would not be expected if an abnormal placental cord insertion recognized at delivery routinely led to a request for a placental pathologic examination, consistent with institutional and published guidelines. 15 Moreover, the velamentous cord insertion prevalence of 0.44% during the study period was consistent with previously published frequencies of 0.4% to 2.4%. [1] [2] [3] 5, 7, 9, 10, 12 As noted, since cases and controls were matched for gestational age at delivery, we could not evaluate any association between velamentous cord insertion and prematurity, which has been previously reported. Nonetheless, we believe that the benefits of this approach to eliminate outcome confounding outweighed this disadvantage. Finally, despite the large numbers of velamentous cord insertions in singletons and twins, we acknowledge that in some instances, statistical significance may not have been achieved because of the sample size. Alternatively, the increased frequency of adverse perinatal outcomes intrinsically associated with twins may have overshadowed any additional risks incurred by the presence of velamentous cord insertion in this cohort.
In summary, velamentous cord insertion without vasa previa is associated with adverse outcomes in singleton and twin gestations. This study cannot address the question of whether antepartum fetal surveillance or modifying antepartum and intrapartum care can reduce the frequency of velamentous cord insertion-associated adverse outcomes. However, given the association of velamentous cord insertion and adverse perinatal outcomes, research specifically addressing these questions is warranted. Approximately one-fourth to one-third of velamentous cord insertions are prenatally diagnosed by ultrasound. Although a lower maternal BMI and anterior placentas may be associated with improved detection, diagnosis may be hampered when the placenta is located posteriorly in twins. Further research is needed to develop uniform, accurate, and reproducible ultrasound criteria for diagnosing velamentous cord insertion and imaging protocols permitting consistent, accurate, and reliable characterization of the placental cord insertion, as well as to determine how best to care for pregnancies when velamentous cord insertion is identified.
